Cochlear

Cochlear is a global leader in the medical devices and equipment industry, specializing in the design, manufacture, and supply of advanced hearing solutions. Since its founding in 1981, the company has pioneered implantable hearing technology, including the Nucleus cochlear implant, the Hybrid electro-acoustic implant, and the Baha bone conduction implant. These products are engineered to restore hearing for individuals with varying degrees of hearing loss, leveraging wireless connectivity and smart mobile app integration to enhance user outcomes.

Operating with a workforce of 5,000-10,000 employees, Cochlear maintains a robust international presence across 17 locations. The company’s operational footprint is anchored by its primary facility in New South Wales, Australia. Learn about Cochlear's global headquarters for detailed geographic and operational information regarding their primary research and manufacturing hub. The company continues to invest in R&D to maintain its competitive edge in the global medical technology market.

Cochlear competes with major industry players such as Sonova, Med-El, and Advanced Bionics, maintaining a strong market position through continuous innovation in implantable devices. The organization is supported by a diverse team of professionals dedicated to medical and health advancements. Meet Cochlear's team to explore the leadership and organizational structure driving their mission. With a focus on B2B and B2C channels, Cochlear remains a critical entity in the global hearing health sector, consistently delivering high-performance medical hardware.